Status:
RECRUITING
A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
Lead Sponsor:
Fondazione EMN Italy Onlus
Collaborating Sponsors:
Amgen
GlaxoSmithKline
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational study is the creation of a national multiple myeloma registry to monitor the current routine clinical practice in Italy and describe the standard of care adopted for the ...
Detailed Description
In Italy, myeloma accounts for 1.3% of all tumour diagnoses in males and for 1.2% of all tumour diagnoses in women. The incidence is 9.5 new cases per 100,000 males and 8.1 cases per 100,000 females. ...
Eligibility Criteria
Inclusion Criteria:
- Patients of both sexes
- Age ≥ 18 years
- Diagnosis of active/symptomatic multiple myeloma (according to CRAB and biological parameters) no earlier than 1st January 2019
- Able and willing to sign an informed consent form
Exclusion Criteria:
- None considered
Key Trial Info
Start Date :
March 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
1900 Patients enrolled
Trial Details
Trial ID
NCT05001087
Start Date
March 16 2021
End Date
March 31 2027
Last Update
February 27 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
A.O.U di Careggi
Florence, Firenze, Italy, 50134
2
AOU Ospedali Riuniti Umberto I
Ancona, Italy
3
Policlinico di Bari - Ematologia con Trapianto
Bari, Italy
4
Policlinico di Bari
Bari, Italy